-
2
-
-
33644874026
-
Time is brain-quantified
-
Saver JL. Time is brain-quantified. Stroke. 2006;37(1):263-6.
-
(2006)
Stroke
, vol.37
, Issue.1
, pp. 263-266
-
-
Saver, J.L.1
-
3
-
-
52649165720
-
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
-
Hacke W, Kaste M, Bluhmki E, Brozman M, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. NEJM. 2008;359(13):1317-29.
-
(2008)
NEJM
, vol.359
, Issue.13
, pp. 1317-1329
-
-
Hacke, W.1
Kaste, M.2
Bluhmki, E.3
Brozman, M.4
-
4
-
-
71849095831
-
Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): Additional outcomes and subgroup analysis of a randomised controlled trial
-
Bluhmki E, Chamorro A, Dávalos A, et al. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol. 2009;8(12):1095-102.
-
(2009)
Lancet Neurol
, vol.8
, Issue.12
, pp. 1095-1102
-
-
Bluhmki, E.1
Chamorro, A.2
Dávalos, A.3
-
5
-
-
84862625338
-
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): A randomised controlled trial
-
Sandercock P, Wardlaw JM, Lindley RI, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet. 2012;379(9834):2352-63.
-
(2012)
Lancet
, vol.379
, Issue.9834
, pp. 2352-2363
-
-
Sandercock, P.1
Wardlaw, J.M.2
Lindley, R.I.3
-
6
-
-
80052403906
-
Revised and updated recommendations for the establishment of primary stroke centers: A summary statement from the brain attack coalition
-
Alberts MJ, Latchaw RE, Jagoda A, et al. Revised and updated recommendations for the establishment of primary stroke centers: A summary statement from the brain attack coalition. Stroke. 2011;42:2651-65.
-
(2011)
Stroke
, vol.42
, pp. 2651-2665
-
-
Alberts, M.J.1
Latchaw, R.E.2
Jagoda, A.3
-
9
-
-
84944115903
-
-
American Stroke Association
-
American Stroke Association. Target: Stroke Time Lost is Brain Lost. http://www.strokeassociation.org/idc/groups/heart-public/@wcm/@hcm/@gwtg/documents/downloadable/ucm-308277. pdf.
-
Target: Stroke Time Lost Is Brain Lost
-
-
-
10
-
-
84944115904
-
On behalf of the acute stroke care writing group. Chapter 3: Hyperacute stroke care
-
In Lindsay MP, Gubitz G, Bayley M, Phillips S (Editors) Ottawa, Ontario Canada:Canadian Stroke Network and Heart and Stroke Foundation of Canada
-
Casaubon LK, Suddes M, on behalf of the Acute Stroke Care Writing Group. Chapter 3: Hyperacute Stroke Care. In Lindsay MP, Gubitz G, Bayley M, Phillips S (Editors) on behalf of the Canadian Stroke Best Practices and Standards Advisory Committee Canadian Best Practice Recommendations for Stroke Care. 2013. Ottawa, Ontario Canada:Canadian Stroke Network and Heart and Stroke Foundation of Canada.
-
(2013)
On Behalf of the Canadian Stroke Best Practices and Standards Advisory Committee Canadian Best Practice Recommendations for Stroke Care
-
-
Casaubon, L.K.1
Suddes, M.2
-
12
-
-
0033864825
-
Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke
-
Christou I, Alexandrov AV, Burgin WS, et al. Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke. 2000;3:1812-6.
-
(2000)
Stroke
, vol.3
, pp. 1812-1816
-
-
Christou, I.1
Alexandrov, A.V.2
Burgin, W.S.3
-
13
-
-
84879069684
-
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke
-
Saver JL, Fonarow GC, Smith EE, et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA. 2013;309(23):2480-8.
-
(2013)
JAMA
, vol.309
, Issue.23
, pp. 2480-2488
-
-
Saver, J.L.1
Fonarow, G.C.2
Smith, E.E.3
-
14
-
-
0030054086
-
Magnitude of benefit from earlier thrombolytic treatment in acute myocardial infarction: New evidence fromGrampian region early anistreplase trial (GREAT)
-
Rawles J.. Magnitude of benefit from earlier thrombolytic treatment in acute myocardial infarction: new evidence fromGrampian region early anistreplase trial (GREAT). BMJ. 1996;312(7025):212-5.
-
(1996)
BMJ
, vol.312
, Issue.7025
, pp. 212-215
-
-
Rawles, J.1
-
15
-
-
0034931505
-
The golden hour: Scientific fact or medical urban legend
-
Lerner EB, Moscati RM. The golden hour: scientific fact or medical "urban legend"? Acad Emerg Med. 2001;8(7):758-60.
-
(2001)
Acad Emerg Med
, vol.8
, Issue.7
, pp. 758-760
-
-
Lerner, E.B.1
Moscati, R.M.2
-
16
-
-
77952112006
-
Time to treatment with intravenous alteplase and outcome in stroke: An updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
-
Lees KR, Bluhmki E, Von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375(9729):1695-703.
-
(2010)
Lancet
, vol.375
, Issue.9729
, pp. 1695-1703
-
-
Lees, K.R.1
Bluhmki, E.2
Von Kummer, R.3
-
17
-
-
33747057446
-
Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment
-
Lindsberg PJ, Häppölä O, Kallela M, Valanne L, KuismaM, Kaste M. Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment. Neurology. 2006;67(2):334-6.
-
(2006)
Neurology
, vol.67
, Issue.2
, pp. 334-336
-
-
Lindsberg, P.J.1
Häppölä, O.2
Kallela, M.3
Valanne, L.4
Kuismam Kaste, M.5
-
18
-
-
84867879470
-
Reducing in-hospital delay to 20 minutes in stroke thrombolysis
-
Meretoja A, Strbian D, Mustanoja S, Tatlisumak T, Lindsberg PJ, Kaste M. Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology. 2012;79(4):306-13.
-
(2012)
Neurology
, vol.79
, Issue.4
, pp. 306-313
-
-
Meretoja, A.1
Strbian, D.2
Mustanoja, S.3
Tatlisumak, T.4
Lindsberg, P.J.5
Kaste, M.6
-
19
-
-
84884526342
-
Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months
-
Meretoja A, Weir L, Ugalde M, et al. Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months. Neurology. 2013;81(12):1071-6.
-
(2013)
Neurology
, vol.81
, Issue.12
, pp. 1071-1076
-
-
Meretoja, A.1
Weir, L.2
Ugalde, M.3
-
20
-
-
80053298469
-
Improving door-to-needle times in acute ischemic stroke: The design and rationale for the American Heart Association/American stroke association's target: Stroke initiative
-
Fonarow GC, Smith EE, Saver JL, et al. Improving door-to-needle times in acute ischemic stroke: The design and rationale for the american heart association/american stroke association's target: Stroke initiative. Stroke. 2011;42:2983-9.
-
(2011)
Stroke
, vol.42
, pp. 2983-2989
-
-
Fonarow, G.C.1
Smith, E.E.2
Saver, J.L.3
-
21
-
-
84898811265
-
Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after initiation of a quality improvement initiative
-
Fonarow GC, Zhao X, Smith EE, et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after initiation of a quality improvement initiative. JAMA. 2014;311(16):1632-40.
-
(2014)
JAMA
, vol.311
, Issue.16
, pp. 1632-1640
-
-
Fonarow, G.C.1
Zhao, X.2
Smith, E.E.3
-
22
-
-
80053298469
-
Improving door-to-needle times in acute ischemic stroke the design and rationale for the American Heart Association/American Stroke Association's target: Stroke initiative
-
Fonarow GC, Smith EE, Saver JL, et al. Improving door-to-needle times in acute ischemic stroke the design and rationale for the American Heart Association/American Stroke Association's target: stroke initiative. Stroke. 2011;42(10):2983-9.
-
(2011)
Stroke
, vol.42
, Issue.10
, pp. 2983-2989
-
-
Fonarow, G.C.1
Smith, E.E.2
Saver, J.L.3
-
23
-
-
84863663502
-
-
Canadian Stroke Network
-
Canadian Stroke Network. The Quality of Stroke Care in Canada. 2011. http://www.canadianstrokenetwork.ca/wp-content/uploads/2011/06/QoSC-EN1.pdf.
-
(2011)
The Quality of Stroke Care in Canada
-
-
-
25
-
-
67650079313
-
A review of the evidence for the use of telemedicine within stroke systems of care. A scientific statement from the American Heart Association/American Stroke Association
-
Schwamm LH, Holloway RG, Amarenco P, et al. A review of the evidence for the use of telemedicine within stroke systems of care. A scientific statement from the American Heart Association/American Stroke Association. Stroke. 2009;40:2616-34.
-
(2009)
Stroke
, vol.40
, pp. 2616-2634
-
-
Schwamm, L.H.1
Holloway, R.G.2
Amarenco, P.3
Al, E.4
|